Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. Thomson Medical to provide benefits for Great Eastern Life policyholders 2. SingHealth and Philips ink MoU to advance digital-first healthcare 3. Singapore to establish new communicable diseases agency in April 4. UAE to maintain strong medical device trade with Iran 5. Fortis to acquire Jalandhar’s Shrimann Superspeciality Hospital for $53mResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
She shared how healthcare leaders can balance innovation, governance, and patient outcomes to tackle challenges and drive transformation.
